Q1 2023 Holdings
Filed 2023-05-12 | 9 holdings | $240.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $64.2M | 4,425,784 | 26.7% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $57.0M | 4,951,303 | 23.8% |
| Amryt Pharma plc | Common | 03217L106 | $38.9M | 2,668,843 | 16.2% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $37.3M | 2,738,785 | 15.5% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $22.1M | 2,242,636 | 9.2% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $11.1M | 4,284,172 | 4.6% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $6.1M | 4,050,865 | 2.5% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $2.3M | 3,131,388 | 1.0% |
| Oncorus, Inc. | Common | 68236R103 | $980.2K | 2,849,464 | 0.4% |